Zin Myint

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

Matteo Santoni, Sebastiano Buti, Zin Myint et al. · European Urology Oncology · 2023 · 52 citations · Full text

Differential Effectiveness, Urology, Genitourinary Cancer +7

Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study

Matteo Santoni, Francesco Massari, Zin Myint et al. · Targeted Oncology · 2023 · 34 citations · Full text

Immuno-oncology Combinations, Urology, Kidney Transplant +7

Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies

Aasems Jacob, Rishi Raj, Derek B. Allison et al. · Preprints.org · 2021 · 26 citations · Full text

Androgen Receptor, Urology, Chemoprevention Strategy +11

Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)

Matteo Santoni, Francesco Massari, Zin Myint et al. · Clinical Genitourinary Cancer · 2023 · 26 citations · Full text

Immuno-oncology Combinations, Urology, Genitourinary Cancer +7

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

Ondřej Fiala, Sebastiano Buti, Hideki Takeshita et al. · Cancer Immunology Immunotherapy · 2023 · 26 citations · Full text

Urology, Metastatic Urothelial Carcinoma, Genitourinary Cancer +6